Chemotherapy-Induced Nausea and Vomiting
Top Cited Papers
- 5 June 2008
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (23) , 2482-2494
- https://doi.org/10.1056/nejmra0706547
Abstract
New insights into the pathophysiology of chemotherapy-induced nausea and vomiting, a better understanding of patients at risk, and the availability of new antiemetic agents have all contributed to substantial improvements in emetic control. This review focuses on our current understanding of chemotherapy-induced nausea and vomiting and the status of pharmacologic interventions in its prevention and treatment.Keywords
This publication has 89 references indexed in Scilit:
- A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group studySupportive Care in Cancer, 2007
- Brain Fos expression during 48 h after cisplatin treatment: Neural pathways for acute and delayed visceral sicknessAutonomic Neuroscience, 2007
- New antiemetic drugsAnnals of Oncology, 2006
- Patient expectation is a strong predictor of severe nausea after chemotherapyCancer, 2004
- Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statementSupportive Care in Cancer, 2004
- Delayed emesis: incidence, pattern, prognostic factors and optimal treatmentSupportive Care in Cancer, 2002
- Anticipatory nausea and vomiting in the era of 5-HT 3 antiemeticsSupportive Care in Cancer, 1998
- Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetronEuropean Journal Of Cancer, 1992
- MetoclopramideDrugs, 1983
- The Pharmacology and Clinical Effectiveness of Phenothiazines and Related Drugs for Managing Chemotherapy-induced EmesisDrugs, 1983